Recurrent mutations in IDH1 were identified in 2008 during an integrated genomic analysis of a set of human glioblastoma tumor samples, and subsequently IDH2 was identified in 2009 in a set of glioma tumor samples [18,19]. The gene discussed is IDH2; the disease is glioblastoma.